4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))

C148H108N16O4Pt4 — CID 157427299

IUPAC4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))
SMILESCC(C)(C)c1ccnc(-c2[c-]c(Oc3[c-]c(-c4cc(C(C)(C)C)ccn4)ccc3-c3ccccc3)c(-c3ccccc3)cc2)c1.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)c4ccccc4c3)cc3ccccc23)nc2ccccc21.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)c4ncccc4c3)cc3cccnc23)nc2ccccc21.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)cc4ccccc34)c3ccccc3c2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C42H38N2O.2C36H24N4O.C34H22N6O.4Pt/c1-41(2,3)33-21-23-43-37(27-33)31-17-19-35(29-13-9-7-10-14-29)39(25-31)45-40-26-32(18-20-36(40)30-15-11-8-12-16-30)38-28-34(22-24-44-38)42(4,5)6;1-39-33-17-9-7-15-31(33)37-35(39)29-21-25(19-23-11-3-5-13-27(23)29)41-26-20-24-12-4-6-14-28(24)30(22-26)36-38-32-16-8-10-18-34(32)40(36)2;1-39-31-17-9-7-15-29(31)37-35(39)25-19-23-11-3-5-13-27(23)33(21-25)41-34-22-26(20-24-12-4-6-14-28(24)34)36-38-30-16-8-10-18-32(30)40(36)2;1-39-29-13-5-3-11-27(29)37-33(39)25-19-23(17-21-9-7-15-35-31(21)25)41-24-18-22-10-8-16-36-32(22)26(20-24)34-38-28-12-4-6-14-30(28)40(34)2;;;;/h7-24,27-28H,1-6H3;2*3-20H,1-2H3;3-18H,1-2H3;;;;/q4*-2;4*+2
InChIKeyOUJMMWIEZXMGHO-UHFFFAOYSA-N
MW2954.91 g/mol
LogP35.39
Rot. Bonds18

About 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))

4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+)) (PubChem CID 157427299) has the molecular formula C148H108N16O4Pt4 and a molecular weight of 2954.91 g/mol. Its IUPAC name is 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+)).

Molecular Properties

Compound Name4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))
PubChem CID157427299
Molecular FormulaC148H108N16O4Pt4
Molecular Weight2954.91 g/mol
Exact Mass2952.73
IUPAC Name4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))
SMILESCC(C)(C)c1ccnc(-c2[c-]c(Oc3[c-]c(-c4cc(C(C)(C)C)ccn4)ccc3-c3ccccc3)c(-c3ccccc3)cc2)c1.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)c4ccccc4c3)cc3ccccc23)nc2ccccc21.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)c4ncccc4c3)cc3cccnc23)nc2ccccc21.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)cc4ccccc34)c3ccccc3c2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C42H38N2O.2C36H24N4O.C34H22N6O.4Pt/c1-41(2,3)33-21-23-43-37(27-33)31-17-19-35(29-13-9-7-10-14-29)39(25-31)45-40-26-32(18-20-36(40)30-15-11-8-12-16-30)38-28-34(22-24-44-38)42(4,5)6;1-39-33-17-9-7-15-31(33)37-35(39)29-21-25(19-23-11-3-5-13-27(23)29)41-26-20-24-12-4-6-14-28(24)30(22-26)36-38-32-16-8-10-18-34(32)40(36)2;1-39-31-17-9-7-15-29(31)37-35(39)25-19-23-11-3-5-13-27(23)33(21-25)41-34-22-26(20-24-12-4-6-14-28(24)34)36-38-30-16-8-10-18-32(30)40(36)2;1-39-29-13-5-3-11-27(29)37-33(39)25-19-23(17-21-9-7-15-35-31(21)25)41-24-18-22-10-8-16-36-32(22)26(20-24)34-38-28-12-4-6-14-30(28)40(34)2;;;;/h7-24,27-28H,1-6H3;2*3-20H,1-2H3;3-18H,1-2H3;;;;/q4*-2;4*+2
InChIKeyOUJMMWIEZXMGHO-UHFFFAOYSA-N
XLogP35.39
TPSA195.40 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds18
Heavy Atoms172
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002954.91
LogP ≤ 535.39
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))?
The IUPAC name of 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+)) (CID 157427299) is 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+)).
What is the SMILES notation for 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))?
The canonical SMILES for 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+)) is CC(C)(C)c1ccnc(-c2[c-]c(Oc3[c-]c(-c4cc(C(C)(C)C)ccn4)ccc3-c3ccccc3)c(-c3ccccc3)cc2)c1.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)c4ccccc4c3)cc3ccccc23)nc2ccccc21.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)c4ncccc4c3)cc3cccnc23)nc2ccccc21.Cn1c(-c2[c-]c(Oc3[c-]c(-c4nc5ccccc5n4C)cc4ccccc34)c3ccccc3c2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))?
The InChIKey is OUJMMWIEZXMGHO-UHFFFAOYSA-N. The full InChI is InChI=1S/C42H38N2O.2C36H24N4O.C34H22N6O.4Pt/c1-41(2,3)33-21-23-43-37(27-33)31-17-19-35(29-13-9-7-10-14-29)39(25-31)45-40-26-32(18-20-36(40)30-15-11-8-12-16-30)38-28-34(22-24-44-38)42(4,5)6;1-39-33-17-9-7-15-31(33)37-35(39)29-21-25(19-23-11-3-5-13-27(23)29)41-26-20-24-12-4-6-14-28(24)30(22-26)36-38-32-16-8-10-18-34(32)40(36)2;1-39-31-17-9-7-15-29(31)37-35(39)25-19-23-11-3-5-13-27(23)33(21-25)41-34-22-26(20-24-12-4-6-14-28(24)34)36-38-30-16-8-10-18-32(30)40(36)2;1-39-29-13-5-3-11-27(29)37-33(39)25-19-23(17-21-9-7-15-35-31(21)25)41-24-18-22-10-8-16-36-32(22)26(20-24)34-38-28-12-4-6-14-30(28)40(34)2;;;;/h7-24,27-28H,1-6H3;2*3-20H,1-2H3;3-18H,1-2H3;;;;/q4*-2;4*+2.
What are the key properties of 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+))?
4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+)) has a molecular weight of 2954.91 g/mol, XLogP of 35.39, 18 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 4-tert-butyl-2-[3-[5-(4-tert-butyl-2-pyridinyl)-2-phenylbenzene-6-id-1-yl]oxy-4-phenylbenzene-2-id-1-yl]pyridine;8-(1-methylbenzimidazol-2-yl)-6-[[8-(1-methylbenzimidazol-2-yl)-7H-quinolin-7-id-6-yl]oxy]-7H-quinolin-7-ide;1-methyl-2-[3-[[4-(1-methylbenzimidazol-2-yl)-3H-naphthalen-3-id-2-yl]oxy]-2H-naphthalen-2-id-1-yl]benzimidazole;1-methyl-2-[4-[[3-(1-methylbenzimidazol-2-yl)-2H-naphthalen-2-id-1-yl]oxy]-3H-naphthalen-3-id-2-yl]benzimidazole;tetrakis(platinum(2+)) is sourced from PubChem (CID 157427299), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).